(Q39595024)

13 September 2017

Arsenic trioxide induces apoptosis of p53 null osteosarcoma MG63 cells through the inhibition of catalase (English)

1 reference

13 September 2017

0 references

Yang Wang

1

1 reference

13 September 2017

Yudan Wei

2

1 reference

13 September 2017

Haiying Zhang

3

1 reference

13 September 2017

Yanfen Shi

4

1 reference

13 September 2017

Yulin Li

5

1 reference

13 September 2017

Ronggui Li

6

1 reference

13 September 2017

language of work or name

1 reference

10 February 2011

1 reference

13 September 2017

1 reference

13 September 2017

29

1 reference

13 September 2017

2

1 reference

13 September 2017

1328-1334

1 reference

https://scigraph.springernature.com/pub.10.1007/s12032-011-9848-5

13 September 2017

0 references

cites work

Targeting the osteosarcoma cancer stem cell

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9848-5

The presence of p53 mutations in human osteosarcomas correlates with high levels of genomic instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9848-5

Association of loss of heterozygosity at the p53 locus with chemoresistance in osteosarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9848-5

Arsenic trioxide - An old drug rediscovered

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9848-5

Basic mechanisms of arsenic trioxide (ATO)-induced apoptosis in human leukemia (HL-60) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9848-5

External auditory canal and middle ear relapse of acute promyelocytic leukemia treated with arsenic trioxide: case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9848-5

Inhibition of cell proliferation and the action mechanisms of arsenic trioxide (As2O3) on human breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9848-5

Darinaparsin: a novel organic arsenical with promising anticancer activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9848-5

Arsenic trioxide induces apoptosis and G2/M phase arrest by inducing Cbl to inhibit PI3K/Akt signaling and thereby regulate p53 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9848-5

Arsenic trioxide augments Chk2/p53-mediated apoptosis by inhibiting oncogenic Wip1 phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9848-5

Arsenic trioxide-induced growth arrest of human hepatocellular carcinoma cells involving FOXO3a expression and localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9848-5

Arsenic trioxide-mediated growth inhibition of myeloma cells is associated with an extrinsic or intrinsic signaling pathway through activation of TRAIL or TRAIL receptor 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9848-5

Arsenic induces apoptosis of human umbilical vein endothelial cells through mitochondrial pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9848-5

Oxidative stress and apoptosis: a new treatment paradigm in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9848-5

Induction of oxyradicals by arsenic: implication for mechanism of genotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9848-5

Association of oxidative stress with realgar-induced differentiation in human leukemia HL-60 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9848-5

Signal transduction pathways and transcription factors triggered by arsenic trioxide in leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9848-5

Dose- and time-dependent response of human leukemia (HL-60) cells to arsenic trioxide treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9848-5

Arsenic trioxide therapy for relapsed acute promyelocytic leukemia: an useful salvage therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9848-5

Biology and therapeutic advances for pediatric osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9848-5

Adjuvant and neoadjuvant combination chemotherapy for osteogenic sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9848-5

Mitochondria in homeostasis of reactive oxygen species in cell, tissues, and organism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9848-5

Clinical review: oxygen as a signaling molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9848-5

Modulation of arsenic trioxide-induced apoptosis by genistein and functionally related agents in U937 human leukaemia cells. Regulation by ROS and mitogen-activated protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9848-5

Taurine protects rat testes against NaAsO(2)-induced oxidative stress and apoptosis via mitochondrial dependent and independent pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9848-5

TGF-beta1 triggers oxidative modifications and enhances apoptosis in HIT cells through accumulation of reactive oxygen species by suppression of catalase and glutathione peroxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9848-5

Prognostic factors and outcomes for osteosarcoma: An international collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9848-5

Arsenic trioxide selectively induces early and extensive apoptosis via the APO2/caspase-8 pathway engaging the mitochondrial pathway in myeloma cells with mutant p53.

21 January 2018

1 reference

12 December 2020

Suppression of arsenic trioxide-induced apoptosis in HeLa cells by N-acetylcysteine.

1 reference

12 December 2020

Arsenic trioxide induces p53-dependent apoptotic signals in myeloma cells with SiRNA-silenced p53: MAP kinase pathway is preferentially activated in cells expressing inactivated p53

1 reference

12 December 2020

Parthenolide-induced apoptosis in multiple myeloma cells involves reactive oxygen species generation and cell sensitivity depends on catalase activity

1 reference

12 December 2020

Analysis of mutant P53 protein in osteosarcomas and other malignant and benign lesions of bone

1 reference

12 December 2020

10.1007/S12032-011-9848-5

Identifiers

DOI

1 reference

13 September 2017

1 reference